Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dr. Reddy's Laboratories Ltd ADR (NY: RDY )

14.21 +0.22 (+1.61%)
Streaming Delayed Price Updated: 3:32 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dr. Reddy's Laboratories Ltd ADR

< Previous 1 2 3 4 5 6 Next >
Dr. Reddy's Laboratories Announces Filing of Annual Report on Form 20-F
From Dr. Reddy’s Laboratories Limited
Via Business Wire
Moderna Stock Surges To Record High As Covid Battle Rages In India
Moderna stock surged to a record high Tuesday after its Covid vaccine protected against a handful of variants in an early-phase study. 
Via Investor's Business Daily
Exposures COVID-19
Saint Warren
Today the WTI oil price rose further up over 1%. 
Via Talk Markets
Crazy Thursday
Today the US stock market went ballistic probably because of a higher joblessness level than expected. 
Via Talk Markets
Why Amarin Fell Again Today
Another Vascepa generic is launched in the U.S. 
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Reconsidered Boom
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded. 
Via Talk Markets
Dr. Reddy's Laboratories Announces the Launch of Icosapent Ethyl Capsules, 1 Gram in the U.S. Market
From Dr. Reddy’s Laboratories Ltd.
Via Business Wire
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
Via Benzinga
Two Rate Hikes In 2023
This afternoon our Fed chief Jerome Powell predicted there will be interest rate hikes faster than before. The news hit US stocks, gold, and bitcoin hard. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 255 companies made new 52-week highs. Points of Interest: The largest company by market cap to set a new 52-week high was Adobe (... 
Via Benzinga
Fan Hit
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares. 
Via Talk Markets
More Inflationary Pressures
Today, we saw more evidence of worrying inflationary pressures from the personal consumption index hitting 3.1% in April over prior April, up sharply from the March rise of 1.9%. 
Via Talk Markets
Sterling At Five-Year High
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro. 
Via Talk Markets
Worldwide Upbeat
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Tourism Trouble
Today stock markets globally moved into the red, because of mounting fear of inflation along with China's crackdown on crypto-currencies. 
Via Talk Markets
Another Tough Day For Markets
The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.” 
Via Talk Markets
Friday Of The Heavy Week
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today 
Via Talk Markets
Dr Reddy's Rolls Out Sputnik V COVID-19 Vaccine In India At $13.58/Dose
Dr. Reddy's Laboratories Ltd (NYSE: RDY) said that it expects to get 36 million doses of Sputnik V COVID-19 vaccine in the next couple of months under its... 
Via Benzinga
Exposures COVID-19
Dr. Reddy's Laboratories Announces the Launch of Ertapenem for Injection in the U.S. Market
From Dr. Reddy’s Laboratories Ltd.
Via Business Wire
Heavy Global Erosion
It is an everything-down day. Even the news is down because commenters are being careful. 
Via Talk Markets
Why Is No One Talking About Dr. Reddy's Stock?
The large generics manufacturer's share price is up more than 35% over the past year. 
Via The Motley Fool
Gold Up Four Days In A Row
The dollar is at a nearly 3 month low. 
Via Talk Markets
3 Global Value Stocks to Buy Now
Tired of expensive stocks being just of reach? Look abroad for some great buying opportunities. 
Via The Motley Fool
Another Heavy News Day
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week. 
Via Talk Markets
Dr. Reddy's Laboratories Announces the Launch of Albendazole Tablets, USP in the U.S. Market
From Dr. Reddy’s Laboratories Ltd.
Via Business Wire
Merck Teams Up With Five Indian Generic Players To Expand COVID-19 Drug Access, Production
Merck & Co Inc (NYSE: MRK) has partnered with five Indian generic drugmakers to expand production and access to Molnupiravir, its experimental oral... 
Via Benzinga
Exposures COVID-19
Friday Market Report
Schlumberger Ltd of Curação today reported on its Q1 results which were good. 
Via Talk Markets
Gold Is Back
Wednesday was another mixed day with oil stocks and foreign telcos up from demand rising--but US telcos going their own ways, with AT&T up, and Verizon down because it lost wireless subs. 
Via Talk Markets
Electric Cancer Cure
Most US stocks were down on fear of inflation and financial risks but then rose after lunch. 
Via Talk Markets
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS